Clomipramine is a tricyclic antidepressant belonging to the dibenzazepine class of compounds. It is prescribed primarily for the treatment of obsessive-compulsive disorder and related anxiety conditions. Clinically it is used to reduce compulsive thoughts and behaviors by modulating serotonergic tone. Pharmacologically, Clomipramine blocks the serotonin transporter, thereby decreasing reuptake of serotonin into presynaptic neurons. This inhibition leads to increased extracellular serotonin concentrations in the brain. The elevated serotonin enhances activation of postsynaptic receptors, which contributes to mood stabilization and anxiolysis. Additionally, Clomipramine exhibits weak antagonism at histamine and muscarinic receptors, producing sedative and anticholinergic side effects. The overall pharmacological profile reflects a balance between serotonergic inhibition and peripheral receptor blockade, supporting its therapeutic efficacy.

Clomipramine is a tricyclic antidepressant belonging to the dibenzazepine class. It is primarily used to treat obsessive compulsive disorder and depression. The drug exerts its therapeutic effect by inhibiting the reuptake of serotonin and norepinephrine. By blocking these transporters it increases the concentration of neurotransmitters in the synaptic cleft. This elevation enhances serotonergic signaling that helps regulate mood and anxiety. The increased serotonin availability contributes to reduced compulsive behaviors associated with obsessive compulsive disorder. Clomipramine also exhibits partial agonist activity at certain serotonin receptors which may augment its effects. Overall the medication modulates central neurotransmission to achieve its clinical benefits.

Clomipramine is a tricyclic antidepressant that can affect various physiological systems. Some individuals may experience drowsiness or fatigue after taking the medication. Dry mouth and constipation are common gastrointestinal side effects. Weight changes such as modest gain or loss can occur over time. Peripheral edema, or swelling of the feet and ankles, has been reported. Cardiovascular effects including mild increases in heart rate have been observed. Rarely, alterations in sexual function such as decreased libido may appear. Most side effects are not severe and often diminish as the body adjusts.

Clomipramine may cause dry mouth as a common side effect. Some people experience blurred vision while taking the medication. It can also lead to dizziness or light-headedness especially after standing quickly. Drowsiness or fatigue is reported by many users during treatment. Constipation, weight gain, and excessive sweating are among the possible physical effects. Occasionally, individuals may notice an increased heart rate or orthostatic low blood pressure. Rarely, sexual dysfunction or mood changes such as agitation can occur.